News & Events
HYPERION THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE™ 2024
During the 2024 J.P. Morgan Healthcare Conference week in San Francisco, Jennings Luu, MD/PhD Fellow and Founder/CEO of the biopharmaceutical startup, will showcase the Company’s latest developments in bringing a new class of medications to market for the treatment of leading global causes of blindness, which include age-related macular degeneration (AMD), diabetic retinopathy (DR), retinitis pigmentosa (RP), and glaucoma.
Newport Beach, CA – December 30, 2023 – Hyperion Therapeutics, Inc., today announced that it is presenting at Seed Showcase, part of Biotech Showcase™ 2024. This year, the Company’s founder and chief executive will be presenting their roadmap for a new class of small-molecule medications, known as Stress Resilience-Enhancing Drugs (SREDs), currently in late-stage preclinical development for the treatment of various age-related and inherited retinal diseases. Based on their revolutionary Systems Pharmacology platform that leverages the latest breakthroughs in multi-omics technologies, SREDs are on track for initial market introduction within five years, and ultimately, hold the potential to be utilized as broad-spectrum therapies with clinical indications spanning a wide variety of acute and chronic conditions associated with aging, stress, and/or neurodegeneration.
1st Place in the Stella Zhang New Venture Competition!
May 25, 2023 — Awarded First Place Prize in Life Sciences at the 2023 Stella Zhang New Venture Competition, hosted by the Beall Center for Innovation and Entrepreneurship in the Merage School of Business at University of California, Irvine. Congratulations to our incredible team for the award-winning pitch!
1st Place in the Morganthaler-Pavey Startup Competition!
April 11, 2023 — Awarded First Place Prize in the Research Track at the 2023 Morganthaler-Pavey Startup Competition, hosted by the Veale Institute for Entrepreneurship at Case Western Reserve University. Congratulations to Jennings Luu, our Founder/CEO (pictured below), for the award-winning pitch!
Stay tuned for more events coming soon
to receive special invitations to upcoming events!
During the academic year, our affiliates from the Center for Translational Vision Research (CTVR) at the University of California, Irvine (UCI) host a critically acclaimed Distinguished Speaker Seminar Series every Friday, 8:30-10:00am PT, which can be accessed in person at UCI or online via the CTVR website. These weekly seminars showcase groundbreaking discoveries by world-renowned researchers on a broad range of topics, including ophthalmology, pharmacology, genetics, biochemistry, neurobiology, imaging, and computational sciences, while engaging our colleagues from UCI, the region, our nation and beyond. Since its inception, the seminar series has grown internationally in scope, with typical weekly attendance including hundreds of participants from around the world... we invite you all to join in on a lively discussion!
Past events with partners & affiliates
Director of the National Eye Institute, Dr. Michael F. Chiang (top left) speaks during his visit to the UCI CTVR as Distinguished Keynote Speaker. September 16, 2022.
Reception honoring the election of Dr. Kris Palczewski (left) to the National Academy of Sciences, featuring Dr. Philip Kiser and Jennings Luu (right) on guitar. June 15, 2022.